Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Zedenius

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Experimental Cell Research|March 19, 2013
Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumorsErik Berglund, David Berglund, Pinar Akcakaya, et al.
Molecular Cancer Therapeutics|February 20, 2025
Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer XenograftsAnja Charlotte Lundgren Mortensen, Hanna Berglund, Preeti Jha, et al.
Endocrine Pathology|June 9, 2026
Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical CarcinomaSamuel Backman, Fredrik Axling, Liang Zhang, et al.
Experimental Cell Research|May 19, 2015
Secretome protein signature of human gastrointestinal stromal tumor cellsErik Berglund, Elisabetta Daré, Rui M M Branca, et al.
The American Journal of Pathology|October 9, 2002
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidismTrisha Dwight, Anne E Nelson, George Theodosopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2014
Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cellsErik Wennerberg, Aline Pfefferle, Lars Ekblad, et al.
Anti-Cancer Drugs|December 24, 2013
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cellsErik Berglund, Sarojini Jayantha Kumari A Ubhayasekera, Fredrik Karlsson, et al.
Oncogene|August 14, 2019
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumorsOmid Fotouhi, Hanna Kjellin, C Christofer Juhlin, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine TumorsOmid Fotouhi, Hanna Kjellin, Catharina Larsson, et al.
Endocrine-Related Cancer|June 12, 2024
Genetic variants and down-regulation of CACNA1H in pheochromocytomaFredrika Svahn, Karolina Solhusløkk Höse, Adam Stenman, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Experimental Cell Research|March 19, 2013
Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumorsErik Berglund, David Berglund, Pinar Akcakaya, et al.
Molecular Cancer Therapeutics|February 20, 2025
Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer XenograftsAnja Charlotte Lundgren Mortensen, Hanna Berglund, Preeti Jha, et al.
Endocrine Pathology|June 9, 2026
Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical CarcinomaSamuel Backman, Fredrik Axling, Liang Zhang, et al.
Experimental Cell Research|May 19, 2015
Secretome protein signature of human gastrointestinal stromal tumor cellsErik Berglund, Elisabetta Daré, Rui M M Branca, et al.
The American Journal of Pathology|October 9, 2002
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidismTrisha Dwight, Anne E Nelson, George Theodosopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2014
Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cellsErik Wennerberg, Aline Pfefferle, Lars Ekblad, et al.
Anti-Cancer Drugs|December 24, 2013
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cellsErik Berglund, Sarojini Jayantha Kumari A Ubhayasekera, Fredrik Karlsson, et al.
Oncogene|August 14, 2019
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumorsOmid Fotouhi, Hanna Kjellin, C Christofer Juhlin, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine TumorsOmid Fotouhi, Hanna Kjellin, Catharina Larsson, et al.
Endocrine-Related Cancer|June 12, 2024
Genetic variants and down-regulation of CACNA1H in pheochromocytomaFredrika Svahn, Karolina Solhusløkk Höse, Adam Stenman, et al.
Pageof 12